We demonstrated that, in contrast to classical opioid receptors, ACKR3 won't induce classical G protein signaling and is not modulated because of the classical prescription or analgesic opioids, like morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists like naloxone. As a substitute, we founded that LIH383, an ACKR3-selective https://zbigniewx162tkb3.wikipresses.com/user